Premium
Reactivation of chronic Chagas’ disease following allogeneic bone marrow transplantation and successful pre‐emptive therapy with benznidazole
Author(s) -
Altclas J.,
Sinagra A.,
Jaimovich G.,
Salgueira C.,
Luna C.,
Requejo A.,
Milovic V.,
Rissio A.,
Feldman L.,
Riarte A.
Publication year - 1999
Publication title -
transplant infectious disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.69
H-Index - 67
eISSN - 1399-3062
pISSN - 1398-2273
DOI - 10.1034/j.1399-3062.1999.010207.x
Subject(s) - medicine , benznidazole , bone marrow transplantation , chronic myelogenous leukemia , parasitemia , disease , transplantation , bone marrow , chagas disease , leukemia , immunology , trypanosoma cruzi , malaria , parasite hosting , world wide web , computer science , plasmodium falciparum
This report shows the early detection of reactivation of chronic Chagas’ disease (CCd) in a 27‐year‐old man with chronic myelogenous leukemia undergoing allogeneic bone marrow transplantation (ABMT). Pre‐emptive therapy with benznidazole during a period of 7 weeks led to a rapid recovery of the patient, who remains free of parasitemia 2 years after the bone marrow transplantation.